comment: Does pityriasis rosea Koebnerise?

comment: Does pityriasis rosea Koebnerise?

Bibliographic Details
Main Authors:	Antonio Chuh, Vijay Zawar
Format:	Article
Language:	English
Published:	Our Dermatology Online 2013-04-01
Series:	Nasza Dermatologia Online
Subjects:	pityriasis rosea
Online Access:	http://www.odermatol.com/issue-in-html/2013-2-11a-comment/

Similar Items

Does pityriasis rosea Koebnerise?
by: Nwabudike Lawrence Chukwudi
Published: (2013-04-01)

Case reports and studies on pityriasis rosea – from number of patients to meta-analyses and diagnostic criteria
by: Vijay Zawar, et al.
Published: (2012-04-01)

Giant pityriasis rosea
by: Zawar Vijay
Published: (2010-01-01)

A Case-Control Study on the Take-Off Sign in Lesional Skin Biopsies of Patients with Pityriasis Rosea
by: Antonio An Tung Chuh, et al.
Published: (2016-10-01)

Pitiríase rósea Pityriasis rosea
by: Sandra Maria Bitencourt Miranda, et al.
Published: (2008-10-01)

Acral pityriasis rosea: A rare variant of pityriasis rosea
by: Pimpa Tantanasrigul, et al.
Published: (2021-05-01)

Doxycycline In Pityriasis Rosea: Placebo- Controlled Clinical Trial
by: Ghassaq Al-Timimi, et al.
Published: (2007-04-01)

The use of antivirals in severe or recalcitrant cases of pityriasis rosea: A case series
by: Lihi Tzur, MD, et al.
Published: (2022-10-01)

What’s old is new: Valacyclovir for the treatment of pityriasis rosea, a retrospective case series
by: Gina M. Ashforth, MD, et al.
Published: (2023-07-01)

Acral pityriasis rosea in an infant with palmoplantar lesions: A novel manifestation
by: Vijay Zawar
Published: (2010-01-01)

Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review
by: Potestio L, et al.
Published: (2024-01-01)

Pityriasis rosea with erythema multiforme - like lesions: An observational analysis
by: Vineet Relhan, et al.
Published: (2013-01-01)

Acyclovir in pityriasis rosea: An observer-blind, randomized controlled trial of effectiveness, safety and tolerability
by: Anupam Das, et al.
Published: (2015-01-01)

Multiple recurrences in Pityriasis rosea - A case report with review of the literature
by: Senthilkumar Sankararaman, et al.
Published: (2014-01-01)

Dupilumab-induced pityriasis rosea
by: Morgan Zabel, BS, et al.
Published: (2023-03-01)

Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine
by: Olivia G. Cohen, et al.
Published: (2021-11-01)

Dupilumab-induced pityriasis rosea in a 28-year-old male with atopic dermatitis
by: Faraz Yousefian, DO, et al.
Published: (2024-03-01)

Pityriasis Rosea and Pityriasis Rosea-like Eruption Following COVID-19 Vaccinations: Case Series from Oman
by: Iman Al Hatmi, et al.
Published: (2023-11-01)

Diagnosis of Pityriasis rosea using a triple light source dermoscope
by: Manmohan Gavvala, et al.
Published: (2021-01-01)

Domperidone‐induced pityriasis rosea‐like drug eruption
by: Sarra Saad, et al.
Published: (2022-04-01)

Vaccine-induced pityriasis rosea and pityriasis rosea-like Eruptions: A review of literature and a case report of COVID-19 vaccine-induced pityriasis rosea
by: Eman Almukhadeb, et al.
Published: (2022-01-01)

An unusual variant: Photo-distributed pityriasis rosea
by: Defne Başkurt, et al.
Published: (2023-12-01)

Pityriasis Rosea Induced by COVID-19 Vaccination
by: Elina Khattab, et al.
Published: (2022-02-01)

Pityriasis rosea in pregnancy: report of a spousal occurrence and craniosynostosis in the healthy newborn
by: Tiffany Y. Loh, et al.
Published: (2016-07-01)

Double-blind randomized placebo-controlled trial to evaluate the efficacy and safety of short-course low-dose oral prednisolone in pityriasis rosea
by: Sidharth Sonthalia, et al.
Published: (2018-08-01)

Narrowband UVB phototherapy in pityriasis rosea
by: Vijayeeta Jairath, et al.
Published: (2015-01-01)

A Case of Persistent Pityriasis Rosea Successfully Treated by a Short Course of Therapy with Abrocitinib
by: Wu H, et al.
Published: (2024-04-01)

The oxidant and antioxidant status in pityriasis rosea
by: Selma Emre, et al.
Published: (2016-01-01)

Pityriasis Rosea Like Drug Rash – A Need to Identify the Disease in Childhood
by: Maitreyee Panda, et al.
Published: (2014-08-01)

Atypical Case of Pityriasis Rosea in a Child Following Streptococcal Erythema Nodosum
by: Chiriac Anca, et al.
Published: (2017-12-01)

Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature
by: Stefano Veraldi, et al.
Published: (2022-07-01)

Study of role of streptococcal throat infection in pityriasis rosea
by: Parija Madhuri, et al.
Published: (2008-01-01)

A case of pityriasis rosea of vidal accompanied by neurofibromatosis type 1
by: Ahu Yorulmaz, et al.
Published: (2015-07-01)

Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination
by: Sun Hye Shin, et al.
Published: (2022-01-01)

Pityriasis Rosea in a Woman and Her Husband – Case Report and Review of the Literature
by: Natalya Lemster, et al.
Published: (2010-08-01)

Clinical and pathological features of 5 cases of children pigmento-genes pityriasis rosea
by: Ting ZHANG, et al.
Published: (2022-12-01)

The relationship between pityriasis rosea, seasonal factors, and other herpetic infections: A time series analysis
by: Sibel Berksoy Hayta, et al.
Published: (2019-01-01)

Reply to “Pityriasis rosea during COVID-19 and its pathogenesis”
by: Dillon Nussbaum, BS, et al.
Published: (2022-12-01)

Effectiveness of acyclovir in the treatment of pityriasis rosea. A systematic review and meta-analysis
by: Milton Rodriguez-Zuniga, et al.
Published: (2018-10-01)

Pityriasis rosea during COVID-19 and its pathogenesis
by: Francesco Drago, MD, et al.
Published: (2022-12-01)